## **Core Concept**
The administration of Fresh Frozen Plasma (FFP) is crucial in the management of postpartum hemorrhage (PPH) when there is evidence of coagulopathy or significant bleeding that does not respond to crystalloid or colloid fluid resuscitation and packed red blood cell (PRBC) transfusion. The decision to transfuse FFP is often guided by laboratory evidence of coagulopathy, such as prolonged PT/INR or aPTT, and clinically significant bleeding.

## **Why the Correct Answer is Right**
The correct approach to determining when to administer FFP in the setting of massive transfusion or significant bleeding involves assessing the patient's coagulation status. A commonly used guideline is the "4:3:1:1" ratio, which refers to the transfusion of 4 units of PRBCs to 3 units of FFP to 1 unit of platelets to 1 unit of cryoprecipitate. However, in many clinical scenarios, especially when laboratory values are not immediately available, FFP is considered after a certain number of units of PRBCs have been transfused, typically after 4-6 units of PRBCs, assuming significant ongoing bleeding. This approach aims to prevent or treat dilutional coagulopathy. Therefore, the administration of FFP after **4** units of blood transfusions is a reasonable approach in the context of significant postpartum hemorrhage.

## **Why Each Wrong Option is Incorrect**
- **Option A:** 2 units is generally too early for FFP administration in the absence of laboratory evidence of coagulopathy, as it may not adequately reflect the development of significant dilutional coagulopathy.
- **Option B:** While some might consider 3 units, the conventional threshold that balances the risk of coagulopathy with the need to avoid unnecessary transfusion is slightly higher.
- **Option D:** 6 units might be too late for some patients, as significant coagulopathy can develop earlier in the course of massive transfusion.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the decision to administer FFP should ideally be guided by laboratory assessment of coagulation (e.g., INR) in addition to clinical judgment. However, in the acute setting of severe hemorrhage, waiting for lab results may not be feasible, making it crucial to have a protocol in place for early consideration of FFP transfusion.

## **Correct Answer:** C. 4.